Related Experiment Video
Updated: Nov 8, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
SARS-CoV-2 proteins regulate inflammatory, thrombotic and diabetic responses in human arterial fibroblasts
Christopher Thor Freda1, Wei Yin1, Berhane Ghebrehiwet2
1Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11794, United States of America.
Abstract:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for many pathological processes, including altered vascular disease development, dysfunctional thrombosis and a heightened inflammatory response. However, there is limited work to determine the underlying cellular responses induced by exposure to SARS-CoV-2 structural proteins. Thus, our objective was to investigate how human arterial adventitial fibroblasts inflammation, thrombosis and diabetic disease markers are altered in response to Spike, Nucleocapsid and Membrane-Envelope proteins. We hypothesized that after a short-term exposure to SARS-CoV-2 proteins, adventitial fibroblasts would have a higher expression of inflammatory, thrombotic and diabetic proteins, which would support a mechanism for altered vascular disease progression. After incubation, the expression of gC1qR, ICAM-1, tissue factor, RAGE and GLUT-4 was significantly up-regulated. In general, the extent of expression was different for each SARS-CoV-2 protein, suggesting that SARS-CoV-2 proteins interact with cells through different mechanisms. Thus, SARS-CoV-2 protein interaction with vascular cells may regulate vascular disease responses.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins trigger inflammation and thrombosis in human arterial fibroblasts. This study reveals how viral proteins impact vascular disease markers, offering insights into COVID-19 complications.
Area of Science:
- Vascular Biology
- Immunology
- Virology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is linked to vascular complications, including thrombosis and inflammation.
- Limited research exists on cellular responses to SARS-CoV-2 structural proteins in vascular cells.
- Understanding these interactions is crucial for elucidating COVID-19's impact on vascular health.
Purpose of the Study:
- To investigate the effects of SARS-CoV-2 structural proteins (Spike, Nucleocapsid, Membrane-Envelope) on human arterial adventitial fibroblasts.
- To determine alterations in inflammatory, thrombotic, and diabetic disease markers following exposure to these viral proteins.
- To hypothesize a mechanism for SARS-CoV-2-induced vascular disease progression.
Main Methods:
- Human arterial adventitial fibroblasts were exposed to purified SARS-CoV-2 structural proteins.
- Expression levels of specific proteins (gC1qR, ICAM-1, tissue factor, RAGE, GLUT-4) were measured.
- Quantitative analysis was performed to assess up-regulation of target markers.
Main Results:
- Exposure to SARS-CoV-2 proteins significantly up-regulated the expression of gC1qR, ICAM-1, tissue factor, RAGE, and GLUT-4 in adventitial fibroblasts.
- The extent of protein expression varied depending on the specific SARS-CoV-2 protein involved.
- These findings suggest distinct interaction mechanisms between different viral proteins and vascular cells.
Conclusions:
- SARS-CoV-2 structural proteins can induce inflammatory and thrombotic responses in vascular cells.
- The observed up-regulation of diabetic markers suggests a link between SARS-CoV-2 infection and metabolic dysregulation in the vasculature.
- These cellular responses mediated by SARS-CoV-2 proteins may contribute to the altered vascular disease progression seen in COVID-19 patients.
Related Concept Videos
The JAK-STAT Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Inflammatory Response I: Vascular and Cellular
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coronary Artery Disease II: Pathophysiology

